Modeling neurological disease using human stem cell-derived microglia-like cells transplanted into rodent brains.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Threats to Benefits: Assessing Knowledge Production in Nonhuman Models of Human Neuropsychiatric Disorders.The Hastings Center report · 2022
   Article
2. Building the brain from scratch: Engineering region-specific brain organoids from human stem cells to study neural development and disease.Current topics in developmental biology · 2021
   Article

Corrections and comments

• Comment on
  Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.2019
• Comment on
  Stem-cell-derived human microglia transplanted in mouse brain to study human disease.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as